RACHEL HIKES: Open Payments
NPI 1821402454 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 61 payments from 12 companies in 2025. Trend: 2023 $1,427 · 2024 $1,740 · 2025 $1,975
Food & beverage: $1,866Education: $109
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $392 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $389 |
| Teva Pharmaceuticals USA, Inc. | 6 | $289 |
| Otsuka America Pharmaceutical, Inc. | 5 | $221 |
| Alkermes, Inc. | 4 | $177 |
| Neurocrine BioSciences, Inc. | 3 | $163 |
| Boston Scientific Corporation | 1 | $116 |
| Lundbeck LLC | 3 | $77 |
| Janssen Pharmaceuticals, Inc | 4 | $72 |
| ABBVIE INC. | 2 | $34 |
Products named: COBENFY, CAPLYTA, UZEDY, LYBALVI, INGREZZA, ABILIFY MAINTENA, General - Pain Management, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
